Although BRCA1 mutations account for a significant proportion of familial breast and ovarian cancers, reduced BRCA1 protein is also reported in sporadic breast cancers, and expression of BRCA1 protein is frequently lost in breast cancer patients; this loss of expression is associated with disruption of critical functions in cells and with cancer development. This evidence concerns the gene BRCA1 and breast carcinoma.